Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial
双重免疫检查点阻断治疗MGMT未甲基化新诊断的胶质母细胞瘤:NRG Oncology BN007,一项随机II/III期临床试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-00618
Lassman, Andrew B; Polley, Mei-Yin C; Iwamoto, Fabio M; Sloan, Andrew E; Wang, Tony J C; Aldape, Kenneth D; Wefel, Jeffrey S; Gondi, Vinai; Gutierrez, Alonso N; Manasawala, Mohammed H; Gilbert, Mark R; Sulman, Erik P; Wolchok, Jedd D; Green, Richard M; Neil, Elizabeth C; Lukas, Rimas V; Goldlust, Samuel A; Snuderl, Matija; Galbraith, Kristyn; Dignam, James J; Won, Minhee; Mehta, Minesh P